Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Teeft.i » - entrée « Median survival »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Median scores < Median survival < Median survival time  Facettes :

List of bibliographic references indexed by Median survival

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
001376 (2012) Keiran S. M. Smalley ; Andrew E. Aplin ; Keith T. Flaherty ; Christoph Hoeller ; Anja K. Bosserhoff ; Nikolas K. Haass ; Marcus Bosenberg ; Antoni Ribas ; Raymond Barnhill ; Ragini Kudchadkar ; Jane L. MessinaMeeting report from the 2011 international melanoma congress, Tampa, Florida
001670 (2010) V. Navaratnam [Royaume-Uni] ; N. Ali [Royaume-Uni] ; Cjp Smith [Royaume-Uni] ; A. Fogarty [Royaume-Uni] ; R B Hubbard [Royaume-Uni]S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival?
001864 (2009) Elin Lindhagen ; Maria Norberg ; Meena Kanduri ; Gerard Tobin ; Laura S Is Nen ; Magnus Berg ; Mats G. Gustafsson ; Christer Sundström ; Richard Rosenquist ; Anna Leskog [Suède]In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia – rolipram and prednisolone active in cells from patients with poor prognosis
001E70 (2005) L. Chung [États-Unis] ; G J Berry [États-Unis] ; E F Chakravarty [États-Unis]Giant cell myocarditis: a rare cardiovascular manifestation in a patient with systemic lupus erythematosus
002633 (1999) P. B. Jensen [Danemark] ; M. Sehested [Danemark] ; S. W. Langer [Danemark] ; H. H. Hansen [Danemark]Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory
002A59 (1996) Abstracts of the Second Biennial Conference of the Federation of Infection Societies
002A76 (1995) Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments
002B06 (1995) Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer
002B08 (1995) Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer
002B18 (1995) Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: A phase II study in stage IIIB-IV non-small cell lung cancer
002B21 (1995) An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Median survival" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Median survival" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Median survival
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021